JIM CRAMERWho's Got the Vaccine?: Cramer's 'Mad Money' Recap (Thursday 7/23/20)By Scott RuttJul 23, 2020 8:56 PM EDT
JIM CRAMERTried and True Tech: Cramer's 'Mad Money' Recap (Wednesday 5/20/20)By Scott RuttMay 20, 2020 8:09 PM EDT
PRESS RELEASESOutlook Therapeutics Bolsters Clinical And Commercial Expertise With Two Key Appointments To Board Of DirectorsBy GlobeNewswireApr 21, 2020 8:05 AM EDT
JIM CRAMERThe Heat Is On: Cramer's 'Mad Money' Recap (Thursday 1/16/20)By Scott RuttJan 16, 2020 8:59 PM EST
JIM CRAMERHealthcare Innovation: Cramer's 'Mad Money' Recap (Monday 1/13/20)By Scott RuttJan 13, 2020 9:01 PM EST
JIM CRAMERInvest in Themes: Cramer's 'Mad Money' Recap (Tuesday 12/10/19)By Scott RuttDec 10, 2019 8:48 PM EST
JIM CRAMERIridium Communications, GW Pharmaceuticals: 'Mad Money' Lightning RoundBy Scott RuttNov 18, 2019 9:12 PM EST
JIM CRAMEROnly the Prices Have Changed: Cramer's 'Mad Money' RecapBy Scott RuttOct 31, 2019 9:02 PM EDT
JIM CRAMERWalt Disney Co., Spotify, Carnival: 'Mad Money' Lightning RoundBy Scott RuttOct 7, 2019 8:50 PM EDT
STOCKSJim Cramer: Let's Wait for Full Story on Promising GW Pharma DrugBy Jim CramerSep 25, 2019 9:08 PM EDT
JIM CRAMERPartisan Acrimony Per Share: Cramer's 'Mad Money' RecapBy Scott RuttSep 24, 2019 8:19 PM EDT
CANNABISGW Pharma Receives EU Approval for CBD-Based Seizure TreatmentBy Tony OwusuSep 23, 2019 8:26 AM EDT
JIM CRAMERBeyond Meat, Yum! Brands, Netflix: 'Mad Money' Lightning RoundBy Scott RuttSep 5, 2019 8:42 PM EDT
INVESTINGGW Pharma Surges on Marijuana-based Epilepsy Drug Sales, Analyst UpgradesBy M. Corey GoldmanAug 7, 2019 10:05 AM EDT
JIM CRAMERBerkshire Hathaway, Seattle Genetics, Zynerba: 'Mad Money' Lightning RoundBy Scott RuttJul 22, 2019 8:35 PM EDT
